Enolase

By Targets:	Enolase (7) Antibiotic (2) Apoptosis (4) Bacterial (2) Biochemical Assay Reagents (1) Endogenous Metabolite (1) MDM-2/p53 (1) Microtubule/Tubulin (1) Parasite (1) Phosphoglycerate Dehydrogenase (PHGDH) (1)
By Research Areas:	Cancer (6) Infection (3) Metabolic Disease (5) Neurological Disease (1)

Targets Recommended: Enolase

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-141412

D-(-)-3-Phosphoglyceric acid disodium 3-Phospho-D-glyceric acid disodium	Enolase Phosphoglycerate Dehydrogenase (PHGDH) MDM-2/p53 Apoptosis	Infection
D-(-)-3-Phosphoglyceric acid (3-Phospho-D-glyceric acid) disodium is an important intermediate in the enzyme-catalyzed glycolysis process. D-(-)-3-Phosphoglyceric acid disodium competitively inhibits yeast enolase (enolase). D-(-)-3-Phosphoglyceric acid disodium can regulate the activity of phosphoglycerate dehydrogenase (PHGDH) to modulate p53 protein and apoptosis .

HY-15858

AP-III-a4 Maximum Cited Publications 9 Publications Verification ENOblock	Enolase Apoptosis	Metabolic Disease Cancer
AP-III-a4 (ENOblock) is a nonsubstrate analogue *enolase* inhibitor with an IC₅₀ of 0.576 uM. AP-III-a4 can be used for the research of cancer and diabetic .

HY-15858A

AP-III-a4 hydrochloride Maximum Cited Publications 9 Publications Verification ENOblock hydrochloride	Enolase Apoptosis	Metabolic Disease Cancer
AP-III-a4 (ENOblock) hydrochloride is a nonsubstrate analogue *enolase* inhibitor with an IC₅₀ of 0.576 uM. AP-III-a4 hydrochloride can be used for the research of cancer and diabetic .

HY-117778

SF2312	Enolase Bacterial Antibiotic	Infection Cancer
SF2312, a natural phosphonate antibiotic (Antibiotic), is a highly potent *Enolase* inhibitor with IC₅₀s of 37.9 nM and 42.5 nM for human recombinant ENO1 and ENO2, respectively. SF2312 is active against bacteria under anaerobic conditions .

HY-117778B

SF2312 ammonium	Enolase Bacterial Antibiotic	Cancer
SF2312 ammonium is the ammonium form of SF2312. SF2312 is a phosphonate antibiotic and *enolase* inhibitor. SF2312 can be isolated from actinomycete Micromonospora, which is active under anaerobic conditions. SF2312 is selectively toxic to ENO1-deleted glioma cells .

HY-131904

POMHEX 3 Publications Verification	Enolase Apoptosis	Metabolic Disease Cancer
POMHEX, a racemic mixture and a cell-permeable pivaloyloxymethyl (POM) proagent of HEX, is a potent, ENO2-specific inhibitor of enolase. POMHEX exhibits low-nanomolar potency against ENO1-deleted cells in vitro and is capable of eradicating ENO1-deleted xenografted tumours in vivo. POMHEX is a potent glycolysis inhibitor .

HY-131904A

Hex	Enolase Parasite	Infection Cancer
Hex is an *enolase* inhibitor and antimalarial agent with K_i values of 74.4 nM and 269.4 nM for ENO2 and ENO1, respectively. Hex is a NfENO and TbENO inhibitor with IC₅₀s value of 0.14 μM and 2.1 μM, respectively. Hex has antimalarial activity against Plasmodium falciparum 3D7, Naegleria fowleri trophozoites and Plasmodium berghei ANKA strain. Hex has anti-tumor effects against intracranial tumors .

HY-P2862

*Enolase*	Biochemical Assay Reagents	Others
Enolase is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

HY-113167

2-Phosphoglyceric acid DL-2-phosphoglyceric acid	Endogenous Metabolite	Metabolic Disease
2-Phosphoglyceric acid (DL-2-phosphoglyceric acid) is a glycolysis substrate. It is catalyzed by enolase into phosphoenolpyruvate (PEP) .

HY-108438

TCS 2210	Microtubule/Tubulin	Neurological Disease
TCS 2210 (compound 1) is a neuronal differentiation inducer in mesenchymal stem cells (MSCs). TCS 2210 increases expression of the neuronal markers β-III tubulin and neuron-specific enolase (NSE) .

Cat. No.	Product Name

HY-L058

Glycolysis Compound Library	956 compounds
Glycolysis is a series of metabolic processes by which one molecule of glucose is catabolized to two molecules of pyruvate with a net gain of two ATP. Glycolysis takes place in 10 steps and catalyzed by a series of enzyme, such as hexokinase, Glucose-6-phosphate isomerase, Phosphofructokinase, etc. Glycolysis is used by all cells in the body for energy generation. Most cancer cells exhibit increased glycolysis and use this metabolic pathway for generation of ATP as a main source of their energy supply. This phenomenon is known as the Warburg effect and is considered as one of the most fundamental metabolic alterations during malignant transformation. Because increased aerobic glycolysis is commonly seen in a wide spectrum of human cancers, development of novel glycolytic inhibitors as a new class of anticancer agents is likely to have broad therapeutic applications. MCE provides a unique collection of 956 glycolysis compounds that mainly target hexokinase, glucokinase, enolase, pyruvate kinase, PDHK, etc. MCE Glycolysis Compound Library is a useful tool for glucose metabolism research and anti-cancer drug discovery.

Glycolysis Compound Library

956 compounds

Glycolysis is a series of metabolic processes by which one molecule of glucose is catabolized to two molecules of pyruvate with a net gain of two ATP. Glycolysis takes place in 10 steps and catalyzed by a series of enzyme, such as hexokinase, Glucose-6-phosphate isomerase, Phosphofructokinase, etc. Glycolysis is used by all cells in the body for energy generation.

Most cancer cells exhibit increased glycolysis and use this metabolic pathway for generation of ATP as a main source of their energy supply. This phenomenon is known as the Warburg effect and is considered as one of the most fundamental metabolic alterations during malignant transformation. Because increased aerobic glycolysis is commonly seen in a wide spectrum of human cancers, development of novel glycolytic inhibitors as a new class of anticancer agents is likely to have broad therapeutic applications.

MCE provides a unique collection of 956 glycolysis compounds that mainly target hexokinase, glucokinase, enolase, pyruvate kinase, PDHK, etc. MCE Glycolysis Compound Library is a useful tool for glucose metabolism research and anti-cancer drug discovery.

Cat. No.	Product Name	Target	Research Area

HY-P4698

Tri-valine NSC 35938	Peptides	Metabolic Disease
Tri-valine (NSC 35938) is a polypeptide that can be separated from Creatine kinase (HY-P2799), β-enolase, Triosephosphate isomerase (HY-P2931) and glyceraldehyde 3-phosphate dehydrogenase .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-117778

SF2312	Structural Classification Natural Products Microorganisms Source classification	Enolase Bacterial Antibiotic
SF2312, a natural phosphonate antibiotic (Antibiotic), is a highly potent *Enolase* inhibitor with IC₅₀s of 37.9 nM and 42.5 nM for human recombinant ENO1 and ENO2, respectively. SF2312 is active against bacteria under anaerobic conditions .

HY-113167

2-Phosphoglyceric acid DL-2-phosphoglyceric acid	Structural Classification Classification of Application Fields Ketones, Aldehydes, Acids Source classification Metabolic Disease Endogenous metabolite Disease Research Fields	Endogenous Metabolite
2-Phosphoglyceric acid (DL-2-phosphoglyceric acid) is a glycolysis substrate. It is catalyzed by enolase into phosphoenolpyruvate (PEP) .

Species:	Human (4) Rat (1) Mouse (1)
Tag:	His (6)
Source:	E. coli (6)

Cat. No.	Compare	Product Name	Species	Source

HY-P75732

	Enolase 3/ENO3 Protein, Human (His) Beta-Enolase; Enolase 3; MSE; Skeletal muscle Enolase	Human	E. coli
	Enolase 3/ENO3 protein acts as a glycolytic enzyme, promoting the conversion of 2-phosphoglycerate into phosphoenolpyruvate. In addition to its role in glycolysis, ENO3 appears to play a crucial role in the development and regeneration of striated muscle. Enolase 3/ENO3 Protein, Human (His) is the recombinant human-derived Enolase 3/ENO3 protein, expressed by E. coli , with N-His labeled tag.

HY-P75253

	Enolase 1/ENO1 Protein, Rat (His) ENO1L1; Eno-1; Alpha-Enolase; NNE; MBP-1; Enolase 1	Rat	E. coli
	Enolase 1 (ENO1) plays a key role in carbohydrate degradation, particularly in the glycolytic pathway, where it catalyzes the conversion of 2-phospho-D-glycerate to phosphoenolpyruvate.This enzyme activity occurs during the fourth step of glycolysis and marks a critical stage in the conversion of glucose to pyruvate.Enolase 1/ENO1 Protein, Rat (His) is the recombinant rat-derived Enolase 1/ENO1 protein, expressed by E.coli , with N-His labeled tag.

HY-P72182

	Enolase 1/ENO1 Protein, Mouse (His) Eno1; Eno-1; Alpha-Enolase; EC 4.2.1.11; 2-phospho-D-glycerate hydro-lyase; Enolase 1; Non-neural Enolase; NNE	Mouse	E. coli
	Enolase 1/ENO1 Proteins, as a glycolytic enzyme, convert 2-phosphoglycerate to phosphoenolpyruvate and have diverse roles in cellular processes like growth control, hypoxia tolerance, and allergic responses. They also function in the fibrinolytic system and stimulate immunoglobulin production, showing their involvement in immune responses. Enolase 1/ENO1 Protein, Mouse (His) is the recombinant mouse-derived Enolase 1/ENO1 protein, expressed by E. coli , with N-10*His labeled tag.

HY-P70260

	Enolase 1/ENO1 Protein, Human (His, solution) rHuAlpha-Enolase, His; Alpha-Enolase; 2-phospho-D-glycerate hydro-lyase; C-myc promoter-binding protein; Enolase 1; MBP-1; MPB-1; Non-neural Enolase; NNE; Phosphopyruvate hydratase; Plasminogen-binding protein; ENO1	Human	E. coli
	The ENO1 protein converts 2-phosphoglycerate to phosphoenolpyruvate and is involved in growth control, hypoxia tolerance, and allergic responses. It acts as a receptor and activator of plasminogen, stimulating immunoglobulin production. ENO1 binds to the myc promoter as a transcriptional repressor and may function as a tumor suppressor. Enolase 1/ENO1 Protein, Human (His, solution) is the recombinant human-derived ENO1, expressed by E. coli , with C-His labeled tag.

HY-P70260A

	Enolase 1/ENO1 Protein, Human (C-His) rHuAlpha-Enolase, His; Alpha-Enolase; 2-phospho-D-glycerate hydro-lyase; C-myc promoter-binding protein; Enolase 1; MBP-1; MPB-1; Non-neural Enolase; NNE; Phosphopyruvate hydratase; Plasminogen-binding protein; ENO1	Human	E. coli
	The ENO1 protein converts 2-phosphoglycerate to phosphoenolpyruvate and is involved in growth control, hypoxia tolerance, and allergic responses. It acts as a receptor and activator of plasminogen, stimulating immunoglobulin production. ENO1 binds to the myc promoter as a transcriptional repressor and may function as a tumor suppressor. Enolase 1/ENO1 Protein, Human (C-His) is the recombinant human-derived Enolase 1/ENO1 protein, expressed by E. coli , with C-6*His labeled tag.

HY-P70271

	*Gamma-enolase/Enolase* 2 Protein, Human (His)** rHuGamma-Enolase/ENO2, His; Gamma-Enolase; 2-phospho-D-glycerate hydro-lyase; Enolase 2; Neural Enolase; Neuron-specific Enolase; NSE; ENO2	Human	E. coli
	Gamma-enolase/Enolase 2 protein exhibits neurotrophic and neuroprotective properties, binding to neocortical neurons and promoting cell survival through a calcium-dependent mechanism. This suggests its potential role in supporting neuron viability within the central nervous system. Gamma-enolase/Enolase 2 Protein, Human (His) is the recombinant human-derived Gamma-enolase/Enolase 2 protein, expressed by E. coli , with N-6*His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P81290B

	NSE Antibody (YA1006) ENO2; Gamma-Enolase; 2-phospho-D-glycerate hydro-lyase; Enolase 2; Neural Enolase; Neuron-specific Enolase; NSE	WB, IHC-F, IHC-P, ICC/IF	Human, Mouse, Rat
	NSE Antibody (YA1006) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1006), targeting NSE, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). NSE Antibody (YA1006) can be used for WB, IHC-F, IHC-P, ICC/IF experiment in human, mouse, rat background.

HY-P83023

	ENO3 Antibody (YA2768) Enolase 3; MSE; GSD13	WB, ICC/IF	Human, Mouse, Rat
	ENO3 Antibody (YA2768) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2768), targeting ENO3, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). ENO3 Antibody (YA2768) can be used for WB, ICC/IF experiment in human, mouse, rat background.

HY-P81290

	NSE Antibody (YA1004) ENO2; Gamma-Enolase; 2-phospho-D-glycerate hydro-lyase; Enolase 2; Neural Enolase; Neuron-specific Enolase; NSE	WB, ELISA	Human, Mouse, Rat
	NSE Antibody (YA1004) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1004), targeting NSE, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). NSE Antibody (YA1004) can be used for WB, ELISA experiment in human, mouse, rat background.

HY-P81290A

	NSE Antibody (YA1005) ENO2; Gamma-Enolase; 2-phospho-D-glycerate hydro-lyase; Enolase 2; Neural Enolase; Neuron-specific Enolase; NSE	WB, ELISA	Human, Mouse, Rat
	NSE Antibody (YA1005) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1005), targeting NSE, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). NSE Antibody (YA1005) can be used for WB, ELISA experiment in human, mouse, rat background.

HY-P81290C

	NSE Antibody (YA1007) ENO2; Gamma-Enolase; 2-phospho-D-glycerate hydro-lyase; Enolase 2; Neural Enolase; Neuron-specific Enolase; NSE	WB, ELISA	Human, Mouse, Rat
	NSE Antibody (YA1007) is a mouse-derived non-conjugated IgG1 antibody (Clone NO.: YA1007), targeting NSE, with a predicted molecular weight of 47 kDa (observed band size: 47 kDa). NSE Antibody (YA1007) can be used for WB, ELISA experiment in human, mouse, rat background.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inhibitors & Agonists

Screening Libraries

Peptides

Natural
Products

Recombinant Proteins

Antibodies